These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33991247)

  • 21. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study.
    Leone J; Zwenger AO; Leone BA; Vallejo CT; Leone JP
    Am J Clin Oncol; 2019 Feb; 42(2):215-220. PubMed ID: 30499840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.
    Abubakar M; Orr N; Daley F; Coulson P; Ali HR; Blows F; Benitez J; Milne R; Brenner H; Stegmaier C; Mannermaa A; Chang-Claude J; Rudolph A; Sinn P; Couch FJ; Devilee P; Tollenaar RA; Seynaeve C; Figueroa J; Sherman ME; Lissowska J; Hewitt S; Eccles D; Hooning MJ; Hollestelle A; Martens JW; van Deurzen CH; ; Bolla MK; Wang Q; Jones M; Schoemaker M; Wesseling J; van Leeuwen FE; Van 't Veer L; Easton D; Swerdlow AJ; Dowsett M; Pharoah PD; Schmidt MK; Garcia-Closas M
    Breast Cancer Res; 2016 Oct; 18(1):104. PubMed ID: 27756439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients.
    Petrelli F; Viale G; Cabiddu M; Barni S
    Breast Cancer Res Treat; 2015 Oct; 153(3):477-91. PubMed ID: 26341751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer.
    Eggemann H; Altmann U; Costa SD; Ignatov A
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):337-341. PubMed ID: 29098396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COX-2, p16 and Ki67 expression in DCIS, microinvasive and early invasive breast carcinoma with extensive intraductal component.
    Bartova M; Ondrias F; Muy-Kheng T; Kastner M; Singer Ch; Pohlodek K
    Bratisl Lek Listy; 2014; 115(7):445-51. PubMed ID: 25077370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of mitotic index and Bcl2 expression in male breast cancer.
    Lacle MM; van der Pol C; Witkamp A; van der Wall E; van Diest PJ
    PLoS One; 2013; 8(4):e60138. PubMed ID: 23573235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.
    Milde-Langosch K; Karn T; Müller V; Witzel I; Rody A; Schmidt M; Wirtz RM
    Breast Cancer Res Treat; 2013 Jan; 137(1):57-67. PubMed ID: 23135572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer.
    Aleskandarany MA; Green AR; Ashankyty I; Elmouna A; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA
    Breast Cancer Res Treat; 2016 Jul; 158(2):287-95. PubMed ID: 27380874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact.
    Nilsson C; Johansson I; Ahlin C; Thorstenson S; Amini RM; Holmqvist M; Bergkvist L; Hedenfalk I; Fjällskog ML
    Acta Oncol; 2013 Jan; 52(1):102-9. PubMed ID: 22928693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ki67 Frequency in Breast Cancers without Axillary Lymph Node Involvement and its Relation with Disease-free Survival.
    Shandiz FH; Shabahang H; Afzaljavan F; Sharifi N; Tavasoli A; Afzalaghaee M; Roshanzamir E; Pasdar A
    Asian Pac J Cancer Prev; 2016; 17(3):1347-50. PubMed ID: 27039770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers.
    Fujimoto Y; Watanabe T; Hida AI; Higuchi T; Miyagawa Y; Ozawa H; Bun A; Fukui R; Sata A; Imamura M; Hirota S; Miyoshi Y
    Breast Cancer; 2019 Nov; 26(6):738-747. PubMed ID: 31098866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of Oncotype Dx score with tumor grade, size, nodal status, proliferative marker Ki67 and Nottingham Prognostic Index in early breast cancer tumors in Saudi Population.
    Durrani S; Al-Mushawa F; Heena H; Wani T; Al-Qahtani A
    Ann Diagn Pathol; 2021 Apr; 51():151674. PubMed ID: 33360027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. St Gallen 2015 subtyping of luminal breast cancers: impact of different Ki67-based proliferation assessment methods.
    Focke CM; van Diest PJ; Decker T
    Breast Cancer Res Treat; 2016 Sep; 159(2):257-63. PubMed ID: 27558625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.
    Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
    Breast Cancer Res Treat; 2018 May; 169(1):33-42. PubMed ID: 29349710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptor-positive invasive ductal breast carcinoma.
    Laurinavicius A; Green AR; Laurinaviciene A; Smailyte G; Ostapenko V; Meskauskas R; Ellis IO
    Oncotarget; 2015 Dec; 6(38):41134-45. PubMed ID: 26512778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Male breast cancer: A closer look at patient and tumor characteristics and factors associated with survival.
    Zhao J; Wang B; Zhao J; Mao Y; Liu J; Yang Y
    Thorac Cancer; 2020 Nov; 11(11):3107-3116. PubMed ID: 32930510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population.
    Wang J; Sang D; Xu B; Yuan P; Ma F; Luo Y; Li Q; Zhang P; Cai R; Fan Y; Chen S; Li Q
    Medicine (Baltimore); 2016 May; 95(18):e3518. PubMed ID: 27149453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between male and female breast cancer survival using propensity score matching analysis.
    Scomersi S; Giudici F; Cacciatore G; Losurdo P; Fracon S; Cortinovis S; Ceccherini R; Zanconati F; Tonutti M; Bortul M
    Sci Rep; 2021 Jun; 11(1):11639. PubMed ID: 34079019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer.
    Carbognin L; Sperduti I; Brunelli M; Marcolini L; Nortilli R; Pilotto S; Zampiva I; Merler S; Fiorio E; Filippi E; Manfrin E; Pellini F; Bonetti F; Pollini GP; Tortora G; Bria E
    J Exp Clin Cancer Res; 2016 Mar; 35():50. PubMed ID: 27000271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reliability of Ki67 visual scoring app compared to eyeball estimate and digital image analysis and its prognostic significance in hormone receptor-positive breast cancer.
    Arun I; Venkatesh S; Ahmed R; Agrawal SK; Leung SCY
    APMIS; 2021 Aug; 129(8):489-502. PubMed ID: 34053140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.